Journal of Clinical Psychiatry Issue 64(9)

Deconstructing Psychiatric Disorders, Part 1: Genotypes, Symptom Phenotypes, and Endophenotypes

Polypharmacy in Patients With Schizophrenia

Feeling Unreal: A Depersonalization Disorder Update of 117 Cases.

Comparison of Risperidone and Olanzapine in the Control of Negative Symptoms of Chronic Schizophrenia and Related Psychotic Disorders in Patients Aged 50 to 65 Years

Aerobic Endurance Exercise Improves Executive Functions in Depressed Patients.

A Placebo-Controlled 18-Month Trial of Lamotrigine and Lithium Maintenance Treatment in Recently Depressed Patients With Bipolar I Disorder

Pilot Trial of Ondansetron in the Treatment of 8 Patients With Obsessive-Compulsive Disorder

Suicide Attempts Among Veterans Seeking Treatment for Pathological Gambling

A 3-Year Naturalistic Study of 53 Preschool Children With Pervasive Developmental Disorders Treated With Risperidone

Aripiprazole for the Prevention of Relapse in Stabilized Patients With Chronic Schizophrenia: A Placebo-Controlled 26-Week Study

Adjunct Modafinil for the Short-Term Treatment of Fatigue and Sleepiness in Patients With Major Depressive Disorder: A Preliminary Double-Blind, Placebo-Controlled Study

Efficacy of Controlled-Release Paroxetine in the Treatment of Late-Life Depression

Incidence of Tardive Dyskinesia in First-Episode Psychosis Patients Treated With Low-Dose Haloperidol

Treatment of Previously Undiagnosed Psychiatric Disorders in Persons With Developmental Disabilities Decreased or Eliminated Self-Injurious Behavior

How Many Subjects With Major Depressive Disorder Meet Eligibility Requirements of an Antidepressant Efficacy Trial?

Suicidal Ideation and Attempts Among Psychiatric Patients With Major Depressive Disorder

Psychoeducation Efficacy in Bipolar Disorders: Beyond Compliance Enhancement

The Use of Atypical Antipsychotics in Nursing Homes

Acute and Long-Term Treatment and Prevention of Relapse of Obsessive-Compulsive Disorder With Paroxetine

Reducing the Risk for Suicide in Schizophrenia and Affective Disorders.

Underdiagnosis of Bipolar II Disorders in the Community

Charles Bonnet Syndrome With Visual Hallucinations of Childhood Experience: Successful Treatment of 1 Patient With Risperidone

Polypharmacy in Schizophrenia: A Fuzzy Concept

Reply to Polypharmacy in Schizophrenia: A Fuzzy Concept

Six-Month Review of Weight and Metabolic Parameters in Patients Receiving Clozapine, Risperidone, Olanzapine, or Quetiapine

Core Competencies for Psychiatric Practice: What Clinicians Need to Know ( A Report of the American Board of Psychiatry and Neurology)

Infanticide: Psychosocial and Legal Perspectives on Mothers Who Kill

Outcomes in Neurodevelopment and Genetic Disorders